Schizophrenia

• FDA approval · 2006-12-19
  FDA Approved: INVEGA — Original Application (Janssen Pharmaceuticals, Inc.)

  The FDA approved Janssen's INVEGA (paliperidone) under an original New Drug Application for the treatment of schizophrenia.

• FDA approval · 2006-11-29
  FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)

  The FDA approved a supplemental application for ZYPREXA (olanzapine) submitted by Eli Lilly and Company.

• FDA approval · 2006-11-29
  FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)

  FDA approved a supplemental NDA to add an intramuscular formulation of ZYPREXA (olanzapine) from Eli Lilly and Company.

• FDA approval · 2006-11-28
  FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)

  FDA approves a supplemental application for Endo USA, Inc.'s generic perphenazine product (ANDA 040226). This action updates the approval fo…

• FDA approval · 2006-10-31
  FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for Clozapine from Mylan Pharmaceuticals Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-10-20
  FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc.

• FDA approval · 2006-10-13
  FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for a generic version of clozapine, manufactured by Mylan Pharmaceuticals Inc.

• FDA approval · 2006-10-06
  FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)

  The FDA has approved a supplemental application for Risperidone submitted by Janssen Pharmaceutical, Inc.

• FDA approval · 2006-09-20
  FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)

  The FDA approved a supplemental application for SEROQUEL (quetiapine) filed by H2-Pharma, LLC.

• FDA approval · 2006-08-25
  FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)

  The FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) from Eli Lilly and Company, expanding the labeling for the Zydis …

• FDA approval · 2006-06-22
  FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)

  FDA approved a supplemental application for Perphenazine (Endo USA, Inc.).